Opthamology @Point of Care Podcasts

S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

25 min · 7. juli 2026
Forsidebilde av episoden S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

Beskrivelse

Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD. Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD [https://suitehome.atpointofcare.com/library/2707.01/page/0?subdomain=dr\&time=1336000\&pre=skip\&utm_source=podcast] to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast [https://pinecast.com].

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Opthamology @Point of Care Podcasts sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

8 Episoder

Forsidebilde av episoden S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD. Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD [https://suitehome.atpointofcare.com/library/2707.01/page/0?subdomain=dr\&time=1336000\&pre=skip\&utm_source=podcast] to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast [https://pinecast.com].

7. juli 202625 min